Sequencing Builds Data Bridges to the Clinic
Searching for Innovative, Cost-Effective Product Options
Custom Manufacturing Accelerates Time to Market
Partners, Not Just Suppliers
Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
David Platt, Ph.D.
David Platt, Ph.D., is CEO of Boston Therapeutics